File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.18632/oncotarget.4218
- Scopus: eid_2-s2.0-84941236552
- PMID: 26215676
- WOS: WOS:000362954800039
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis
Title | A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis |
---|---|
Authors | |
Keywords | Breast cancer Mammary gland development MiR-137 Tachykinin-1 Tumour suppressor |
Issue Date | 2015 |
Publisher | Impact Journals LLC. The Journal's web site is located at http://www.impactjournals.com/oncotarget/index.html |
Citation | Oncotarget, 2015, v. 6 n. 26, p. 22048-22059 How to Cite? |
Abstract | MicroRNAs are differentially expressed in breast cancer cells and have been implicated in cancer formation, tumour invasion and metastasis. We investigated the miRNA expression profiles in the developing mammary gland. MiR-137 was expressed prominently in the developing mammary gland. When the miR-137 was over-expressed in the embryo, the mammary epithelium became thickened. Moreover, genes associated with mammary gland formation such as Tbx3 and Lef1 were not expressed. This suggests that miR-137 induces gland formation and invasion. When miR-137 was over-expressed in MDA-MB-231 cells, their ability to form tumours in adult mice was significantly reduced. These data support miR-137 decides epithelial cell behavior in the human breast cancer. It also suggests that miR-137 is a potential therapeutic target for amelioration of breast cancer progression. |
Persistent Identifier | http://hdl.handle.net/10722/215048 |
ISSN | 2016 Impact Factor: 5.168 2023 SCImago Journal Rankings: 0.789 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, JM | - |
dc.contributor.author | Cho, KW | - |
dc.contributor.author | Kim, EJ | - |
dc.contributor.author | Tang, Q | - |
dc.contributor.author | Kim, KS | - |
dc.contributor.author | Tickle, C | - |
dc.contributor.author | Jung, HS | - |
dc.date.accessioned | 2015-08-21T12:21:01Z | - |
dc.date.available | 2015-08-21T12:21:01Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Oncotarget, 2015, v. 6 n. 26, p. 22048-22059 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | http://hdl.handle.net/10722/215048 | - |
dc.description.abstract | MicroRNAs are differentially expressed in breast cancer cells and have been implicated in cancer formation, tumour invasion and metastasis. We investigated the miRNA expression profiles in the developing mammary gland. MiR-137 was expressed prominently in the developing mammary gland. When the miR-137 was over-expressed in the embryo, the mammary epithelium became thickened. Moreover, genes associated with mammary gland formation such as Tbx3 and Lef1 were not expressed. This suggests that miR-137 induces gland formation and invasion. When miR-137 was over-expressed in MDA-MB-231 cells, their ability to form tumours in adult mice was significantly reduced. These data support miR-137 decides epithelial cell behavior in the human breast cancer. It also suggests that miR-137 is a potential therapeutic target for amelioration of breast cancer progression. | - |
dc.language | eng | - |
dc.publisher | Impact Journals LLC. The Journal's web site is located at http://www.impactjournals.com/oncotarget/index.html | - |
dc.relation.ispartof | Oncotarget | - |
dc.rights | The final published version is available online at http://dx.doi.org/10.18632/oncotarget.4218 | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Breast cancer | - |
dc.subject | Mammary gland development | - |
dc.subject | MiR-137 | - |
dc.subject | Tachykinin-1 | - |
dc.subject | Tumour suppressor | - |
dc.title | A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis | - |
dc.type | Article | - |
dc.identifier.email | Jung, HS: hsjung@hku.hk | - |
dc.identifier.authority | Jung, HS=rp01683 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.18632/oncotarget.4218 | - |
dc.identifier.pmid | 26215676 | - |
dc.identifier.pmcid | PMC4673145 | - |
dc.identifier.scopus | eid_2-s2.0-84941236552 | - |
dc.identifier.hkuros | 248206 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 26 | - |
dc.identifier.spage | 22048 | - |
dc.identifier.epage | 22059 | - |
dc.identifier.isi | WOS:000362954800039 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1949-2553 | - |